Aurobindo Pharma shares fall after USFDA issues 10 observations to API unit in Telangana

The Hyderabad-based pharmaceutical manufacturing company said the observations are of procedural in nature and will be responded to within the stipulated time.

Leave a Reply

Your email address will not be published. Required fields are marked *